Replimune Group, Inc. (REPL) vs STAAR Surgical Company (STAA)
A side-by-side comparison of Replimune Group, Inc. and STAAR Surgical Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
REPL
Replimune Group, Inc.
$13.07HealthcareDelayed quote: Oct 6, 2026, 1:40 PM EDT
STAA
STAAR Surgical Company
$22.18HealthcareDelayed quote: Oct 6, 2026, 1:40 PM EDT
Total return — REPL vs STAA
growth of $100 · dividends reinvested · last 8yREPL -13.3% (-1.8%/yr)STAA -33.4% (-5.0%/yr)REPL compounded faster over this window
REPL STAA
REPL vs STAA: by the numbers
- •STAA is the larger company ($1.10B vs $1.10B market cap).
- •STAA is profitable (1.13% net margin) while REPL runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | REPL | STAA |
|---|---|---|
| P/E ratio | N/A | 277.25 |
| Forward P/E | N/A | 76.41 |
| P/S ratio | N/A | 3.25 |
| P/B ratio | 10.40 | 3.02 |
| EV / EBITDA | N/A | 22.50 |
Profitability
| Metric | REPL | STAA |
|---|---|---|
| Gross margin | 0.00% | 76.23% |
| Operating margin | 0.00% | -19.19% |
| Net margin | 0.00% | 1.13% |
| ROE | -281.14% | 1.05% |
| ROIC | -139.11% | 4.80% |
Growth (annualized)
| Metric | REPL | STAA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.49% |
| Total return CAGR (5Y) | -15.17% | -28.41% |
Frequently asked
- Is REPL or STAA more profitable?
- STAA runs the higher net margin — REPL at 0.00% versus STAA at 1.13%.
- How have REPL and STAA total returns compared?
- Over the past 5 years, REPL delivered -15.17% and STAA delivered -28.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.